Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes.
Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes. Transplantation. 2006 Dec 27; 82(12):1621-4.